Marks, D I <br/><br/>
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Mar 1997 
 - 1158-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1997.15.3.1158  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Child<br/>Child, Preschool<br/>Genes, p53--genetics<br/>Humans<br/>Mutation<br/>Nuclear Proteins<br/>Pilot Projects<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prognosis<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-mdm2<br/>Treatment Failure<br/>Tumor Suppressor Protein p53--metabolism